ID   ESI-035
AC   CVCL_B856
SY   ESI035; SSCCe007-A
DR   hPSCreg; SSCCe007-A
DR   ISCR; 81
DR   NIHhESC; NIHhESC-11-0129
DR   SKIP; SKIP002091
DR   Wikidata; Q54832758
RX   PubMed=18371388;
RX   PubMed=20177998;
RX   PubMed=22265736;
RX   PubMed=28445466;
WW   http://www.esibio.com/products/product-category/cell-lines/esi-035-human-embryonic-stem-cell-line-46-xx/
CC   Group: Clinical grade hESC cell line.
CC   From: ESI BIO - BioTime, Inc. (ES Cell International); Alameda; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0129.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-01.
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg273Gly (c.817C>G); ClinVar=VCV000634682; Zygosity=Unspecified; Note=Somatic mutation acquired during proliferation (PubMed=28445466).
CC   Omics: CNV analysis.
CC   Omics: Deep exome analysis.
CC   Omics: Genome sequenced.
CC   Omics: SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): ESI_BIO
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 12
ST   D18S51: 14,17
ST   D21S11: 28
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 11
ST   D8S1179: 13
ST   FGA: 21,23
ST   Penta D: 9,12
ST   Penta E: 11,14
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 18
//
RX   PubMed=18371388; DOI=10.1016/j.stem.2007.10.004;
RA   Crook J.M., Peura T.T., Kravets L., Bosman A.G., Buzzard J.J.,
RA   Horne R., Hentze H., Dunn N.R., Zweigerdt R., Chua F., Upshall A.,
RA   Colman A.;
RT   "The generation of six clinical-grade human embryonic stem cell
RT   lines.";
RL   Cell Stem Cell 1:490-494(2007).
//
RX   PubMed=20177998; DOI=10.1007/s11626-010-9287-1;
RA   Sivarajah S., Raj G.S., Mathews A.J.V., Sahib N.B.E., Hwang W.-S.,
RA   Crook J.M.;
RT   "The generation of GLP-grade human embryonic stem cell banks from four
RT   clinical-grade cell lines for preclinical research.";
RL   In Vitro Cell. Dev. Biol. Anim. 46:210-216(2010).
//
RX   PubMed=22265736; DOI=10.1016/j.scr.2011.10.001;
RA   Funk W.D., Labat I., Sampathkumar J., Gourraud P.-A., Oksenberg J.R.,
RA   Rosler E.S., Steiger D., Sheibani N., Caillier S., Stache-Crain B.,
RA   Johnson J.A., Meisner L.F., Lacher M.D., Chapman K.B., Park M.J.,
RA   Shin K.-J., Drmanac R., West M.D.;
RT   "Evaluating the genomic and sequence integrity of human ES cell lines;
RT   comparison to normal genomes.";
RL   Stem Cell Res. 8:154-164(2012).
//
RX   PubMed=28445466; DOI=10.1038/nature22312;
RA   Merkle F.T., Ghosh S., Kamitaki N., Mitchell J., Avior Y., Mello C.,
RA   Kashin S., Mekhoubad S., Ilic D., Charlton M., Saphier G.,
RA   Handsaker R.E., Genovese G., Bar S., Benvenisty N., McCarroll S.A.,
RA   Eggan K.C.;
RT   "Human pluripotent stem cells recurrently acquire and expand dominant
RT   negative P53 mutations.";
RL   Nature 545:229-233(2017).
//